Jie Li,Bin Zhang,Zishan Feng,Dandan An,Zhiyuan Zhou,Chao Wan,Yan Hu,Yajie Sun,Yijun Wang,Xixi Liu,Wenwen Wei,Xiao Yang,Jingshu Meng,Mengjie Che,Yuhan Sheng,Bian Wu,Lu Wen,Fang Huang,Yan Li,Kunyu Yang

Abstract:Glioblastoma (GBM) is the most common malignant tumor of the central nervous system. It is an aggressive tumor characterized by rapid proliferation, diffuse tumor morphology, and poor prognosis. Unfortunately, current treatments, such as surgery, radiotherapy, and chemotherapy, are unable to achieve good outcomes. Therefore, there is an urgent need to explore new treatment targets. A detailed mechanistic exploration of the role of the nuclear pore transporter KPNB1 in GBM is lacking. This study demonstrated that KPNB1 regulated GBM progression through a transcription factor YBX1 to promote the expression of post-protrusion membrane protein NLGN3. This regulation was mediated by the deubiquitinating enzyme USP7.

Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis